Literature DB >> 10530489

Inflammation-induced cholestasis.

M Trauner1, P Fickert, R E Stauber.   

Abstract

Inflammatory cytokines produced in response to various infectious and non-infectious stimuli are potent inducers of intrahepatic cholestasis (inflammation-induced cholestasis). The cholestatic effect of cytokines results mainly from inhibition of expression and function of hepatocellular transport systems which normally mediate hepatic uptake and biliary excretion of bile salts and various non-bile salt organic anions (e.g. bilirubin). These cytokine effects are reversible and bile secretory function is restored upon disappearance of the inflammatory injury. This review summarizes the clinical, pathophysiological and molecular aspects of inflammation-induced cholestasis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530489     DOI: 10.1046/j.1440-1746.1999.01982.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  48 in total

1.  Challenging diagnosis--icterus associated with a single perforating duodenal ulcer after long-term nonsteroidal antiinflammatory drug administration in a dog.

Authors:  Felix M Duerr; Anthony P Carr; Trevor N Bebchuk; Neil C Pople
Journal:  Can Vet J       Date:  2004-06       Impact factor: 1.008

2.  Diagnostic value of inflammation markers in predicting perforation in acute sigmoid diverticulitis.

Authors:  S A Käser; G Fankhauser; P M Glauser; D Toia; Christoph A Maurer
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

Review 3.  Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.

Authors:  Gustav Paumgartner
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

Review 4.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

5.  Omega-3 long chain polyunsaturated Fatty acids for treatment of parenteral nutrition-associated liver disease: a review of the literature.

Authors:  Emma M Tillman; Richard A Helms
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

6.  Two case reports of corticosteroid administration-prolonged and pulsed therapy-in treatment of pruritus in cholestatic hepatitis A patients.

Authors:  Daad Daghman; Mohamad Saeed Rez; Amjad Soltany; Almotaman Alsaleh
Journal:  Oxf Med Case Reports       Date:  2019-08-26

7.  Comparison of culture media for bile Acid transport studies in primary human hepatocytes.

Authors:  Lisa-Mari Mörk; Bengt Isaksson; Nicola Boran; Bo-Göran Ericzon; Stephen Strom; Björn Fischler; Ewa Ellis
Journal:  J Clin Exp Hepatol       Date:  2012-12-16

Review 8.  Cholestatic liver (dys)function during sepsis and other critical illnesses.

Authors:  Marc Jenniskens; Lies Langouche; Yoo-Mee Vanwijngaerden; Dieter Mesotten; Greet Van den Berghe
Journal:  Intensive Care Med       Date:  2015-09-21       Impact factor: 17.440

9.  Non-Hodgkin's lymphoma: a cause of paraneoplastic cholestasis.

Authors:  Zaid Alirhayim; Herman Dyal; Abdulqader Alarhayem; Vijayalakshmi Donthireddy
Journal:  BMJ Case Rep       Date:  2013-05-22

10.  Gaps in predicting clinical doses for cannabinoids therapy: Overview of issues for pharmacokinetics and pharmacodynamics modelling.

Authors:  Zheng Liu; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2018-06-07       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.